';
CLOSE
Tags Posts tagged with "ODP"

ODP

0 700
UPDATE: This webinar has been cancelled by ODP
The Family Medical Support Assistance (FMSA) Webinar for Professionals on May 21 has also been cancelled

In 2022, the Office of Developmental Programs (ODP) created the new waiver service Family Medical Support Assistance (FMSA). ODP is scheduling webinars to explain what this service entails, how it works, and who it applies to. ODP is encouraging individuals and families to attend this webinar to learn about this waiver service; there will be time during the webinar for questions to be asked directly to ODP.

Who should attend?
Individuals and Families

Date and Time:
Friday, May 29, 2026
10:00 am – 11:30 am

Please note that this session is intended specifically for individuals and families. ODP is offering a seperate session for professionals.

0 529

The Office of Developmental Programs (ODP) has clarified qualification requirements for Residential Habilitation in the Consolidated Waiver specifically for individuals with a Medically Complex Condition (MCC).

Currently, there are about ten providers qualified to provide Residential Habilitation to individuals with an MCC in the Consolidated Waiver. To ensure that individuals with an MCC have access to needed services, current residential providers are encouraged to become qualified to provide Residential Habilitation to individuals with a MCC.

Please see ODPANN 26-044 for more information and details on the following:

  • Why Should Providers Become Qualified?
  • What are the Steps for Current Residential Providers to become an MCC Residential Habilitation Provider?
  • What are the Responsibilities of the Administrative Entity (AE) to Support Current Residential Providers to become MCC Qualified?

Questions about this communication should be directed to the appropriate ODP Regional Office.

0 447

The Office of Developmental Programs (ODP) has shared ODPANN 26-043, which states that the Temple University Harrisburg Certified Investigator Program will be facilitating the June Forum for Certified Investigators (CI) and others involved in the incident investigation process.

During this forum, ODP and the CI Program staff will explain the new quality review tool and share standards and trends identified during the current quality review process.

Date and Time:
Friday, June 12, 2026
10:00 am – 11:30 am
Topic: “Raising the Standard: The Temple – ODP Investigation Quality Review Process in Depth”
Register Here: CI Forum

Please complete a short survey and submit your topic-related questions before the close of business on Friday, June 5.

View the announcement for more information and details.

0 549
MEDICAID text on a keyboard with stethoscope , medical concept

The Office of Developmental Programs (ODP) has shared a reminder of the importance of supporting individuals in maintaining their eligibility for Medicaid and in verifying an individual’s eligibility for Medicaid prior to delivering services.

Each month, the Office of Developmental Programs (ODP) generates an “MA Reapplications Due Soon” report for each Administrative Entity (AE) and Supports Coordination Organization (SCO). The report is uploaded to the internet version of DocuShare and can be found using the following path:

AEs: ODP –> Division of Program Analysis –> Select Region Folder –> Select County/Joinder Folder –> County Dashboards

Intellectual Disability/Autism (ID/A) SCOs: ODP –> Division of Program Analysis –> ID/A Supports Coordination Organization –> Select Region Folder –> Select the ID/A SCO

Adult Autism Waiver (AAW) SCOs: ODP’s Bureau of Supports for Autism and Special Populations (BSASP) sends each SCO a monthly report of impacted individuals they serve for follow-up. Please note that AAW SCOs who are serving individuals whose MA is not coming due within the next four months will not receive a monthly report.

Please view ODPANN 25-097 for additional details and information.

Attachments:

0 871

The Office of Developmental Programs (ODP) shared this important announcement from the U. S. Food and Drug Administration (FDA). The FDA is aware that Philips has issued a letter to affected customers recommending all Trilogy ventilators be corrected prior to continued use. This includes Trilogy EVO, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal devices.

Philips has identified three issues affecting Trilogy Evo Platform ventilators:

  • Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
  • Aerosol buildup on the internal flow sensor may interfere with the sensor’s ability to accurately measure airflow, leading to incorrect flow calculations and potentially impacting the therapy delivered to the patient.
  • In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards – two breath cycles, or five seconds. In certain ventilation modes, with or without backup rates, the alarm could be delayed by up to four breaths.

This recall involves correcting devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction. View the full list of affected products here.

What to Do:

Update all Trilogy Evo Platform ventilators with software version 1.05.15.00. Stop all use of non-pneumatic nebulizers with all Trilogy Evo Platform ventilators. Review the latest User Manual Addendum.

On March 2, Philips sent all affected customers a letter recommending the following actions:

  • Update all Trilogy Evo Platform ventilators with software version 1.05.15.00. The software is available as free download through the My Philips for Professionals (MyP4P) and InCenter websites.
  • Review the latest version of the User Manual Addendum. Ensure a copy of all product literature, including the User Manual Addendum, is included with every Trilogy Evo Platform ventilator in your fleet.
  • Stop all use of non-pneumatic nebulizers, including vibrating mesh nebulizers, with all Trilogy Evo Platform ventilators.
  • Communicate this notice to anyone in your organization who interacts with a Trilogy Evo Platform ventilator, including clinicians, therapists, nurses, caregivers, and patients. Ensure they are aware of the changes regarding the use of nebulizers with these ventilators and that non-pneumatic nebulizers are not to be used.
  • If a Trilogy Evo Platform ventilator previously in your possession has been transferred, ensure this information is communicated to them, including the User Manual Addendum.

Visit the FDA’s website for additional information and next steps.

0 529

The Office of Developmental Programs (ODP) has shared ODPANN 26-042. This communication announces updated SPeCTRUM training is now available on MyODP for Consolidated and Community Living Waiver Providers. This announcement obsoletes ODPANN 19-072, 19-121, and 20-032.

The updated SPeCTRUM training consists of multiple self-paced modules and has enhanced webinar capabilities, updated content, and has been streamlined while continuing to provide foundational information necessary to support adults with autism spectrum disorder (ASD).

Users must complete all the modules for the training to be considered complete. To satisfy the basic autism training requirement for Residential Performance-Based Contracting measures CN-DD/Bx.01.1S and CN-DD/Bx.01.1CE for all Direct Support Professionals (DSP), Frontline Supervisors (FLS), and program managers must complete SPeCTRUM: Office of Developmental Programs Online Autism Competency Training. This training also fulfills §6100.143 ongoing training requirements. Users will be required to view all 8 modules and receive a 100% on related quiz questions for the training to populate on the MyTranscript Report.

Effective July 1, 2026, previously accepted Relias trainings will no longer be accepted as alternatives for meeting the requirements associated with Residential Performance-Based Contracting measures CN-DD/Bx.01.1S and CN-DD/Bx.01.1CE.

SPeCTRUM training is available on MyODP’s website.

123...105Next Page 1 of 105
© 2021 - Rehabilitation & Community Providers Association